Liver cirrhosis was the main risk factor for HCC development in Brazil.

One patient with preexisting cirrhosis required liver transplantation; all others resolved clinically.

Very little information is available on body composition in patients with cirrhosis.

Conclusions: PPI therapy is associated with SBP in patients with advanced cirrhosis.

Conclusion: Terlipressin decreases hepatic and renal arterial resistance in patients with cirrhosis.